West Island Brands Inc.

OTC: WIBFF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Toronto, ONReports USD

#801 of 1,394 Healthcare companies by revenuetop-decile growth

EA Score

——

FH —DQ —GM —SS 36

v0.1 · 5/100 weight · pillars only

↑ revenue growth (YoY), balance-sheet leverage · ↓ market scale, return on equity

Methodology →

Revenue TTM

$3.5M

Rev growth YoY (TTM)

+159.9%

Net income (FY)

-$4.1M

Employees

—

Market cap

$60.1k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$1.9M2.3M CAD2021

Net income-$4.1M-5.1M CAD2021

Operating income-$3.8M-4.8M CAD2021

Total assets$4.8M6.1M CAD2021

Liabilities$2.3M2.9M CAD2021

Equity$2.6M3.3M CAD2021

Revenue trend

FY2017 – FY2021 · USD

FY17

FY18

FY19

$90.5k

FY20

$1.9M

FY21

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

West Island Brands Inc. booked $1.9M in FY2021 revenue, growing 1950% year over year — faster than 97% of Healthcare companies we track, at a -221.1% net margin.

Peers · Healthcare

Acura Pharmaceuticals, Inc.——Psyence Biomedical Ltd.——Allied Corp.——Endexx Corporation——

Key facts

CEOBoris Ivan Ziger

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersToronto, ON

ExchangeOTC: WIBFF

Employees—

IPO date2015-02-23

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.